ABSTRACT This report describes developments toward a cell specific-locus test for measuring point mutations directly in sperm based upon the use of a monospecific antibody against sperm-specific lactate dehydrogenase-X (LDH-X) The antibody recognizes amino acid differences between mouse and rat LDH-X molecules. In general, mouse sperm do not bind the monospecific antibody against rat LDH-X, but a few exceptional mouse sperm do. Such mouse sperm are believed to contain LDH-X molecules in which an amino acid normally present in mouse LDH-X has been exchanged with one present in rat LDH-X at a place where rat and mouse enzymes are antigenically different. Thus, in the fluorescent antibody technique, mouse sperm carrying normal LDH-X do not stain but the sperm containing mutated enzyme do stain. By using this technique, the spontaneous presumptive mutation frequency in DBA/2 mice was found to be 0.43 X 10-6; it increased to 7.6 X 10-6 upon procarbazine treatment of the mice. There is a growing concern among geneticists that the increase in environmental pollution may be a genetic hazard to humans. The effective control of such genetic injuries requires (a) a practical means of monitoring such injury in exposed individuals, and (b) identifying chemicals that cause mutation or cancer. Several systems, based upon exposure of lower organisms to mutagens, are available to monitor the effect of environmental mutagens. The mammalian mutation systems for the detection of gene mutations require scoring large numbers of animals and, therefore, are not practical for the routine testing of mutagens. As an alternative to monitoring the pedigree, cells from exposed individuals may be considered for screening for point mutations through the use of an appropriate marker protein. The advantage of such a single-cell screening system (cell specific-locus test) would be that each cell, rather than each individual, could be examined for mutational events. Our program to develop cell specific-locus tests is based on the use of antibodies that recognize specific amino acid substitutions in marker proteins present in readily available cells such as sperm. Monospecific* antibody will bind to the "mutant" protein and not to the normal protein. The mutant cells are then identified and quantitated by fluorescent antibody technique.
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For the specific-locus test using sperm, described in this paper, we used lactate dehydrogenase-X (LDH-X, LDH-C, EC 1.1.1.27) as the marker protein; it is an isozyme of LDH that is present only in mature testes and sperm. The sperm tail contains the enzyme on the surface as well as inside, whereas the midpiece contains LDH-X in the cytoplasm and mitochondria but not on the surface (unpublished data).
Lactate dehydrogenase-X is a tetramer of a polypeptide chain known as C subunit (1) (2) (3) (3) . This may be because an effective blood-testes barrier (4) isolates LDH-X from the animal's immune system. Our system for detecting mutation in sperm is based on immunological differences between rat and mouse LDH-X. We have prepared an antibody population that binds rat LDH-X but not mouse LDH-X. In a sandwich fluorescent antibody technique, this antibody stains rat sperm brightly whereas mouse sperm remains unstained. If a mouse LDH-X gene undergoes a mutation such that an amino acid in the mouse LDH-X has been replaced by one normally present in rat LDH-X at that particular position, this altered mouse LDH-X will bind the anti-rat LDH-X antibody, and the mouse sperm containing such mutant molecules can be identified by its immunofluorescent stain.
MATERIALS AND METHODS
Lactate Dehydrogenase-X. Rat and mouse testicles were obtained frozen from Pel-Freeze. LDH-X was purified from testicles by affinity chromatography on AMP-Sepharose followed by DEAE-Sephadex chromatography (5) .
In polyacrylamide gel electrophoresis, purified mouse LDH-X formed a single band whereas rat LDH-X formed two bands because of C4 and AC3 known to be present in rat testes (3) . The C4 band of LDH-X was used for immunization.
Antiserum. Antiserum against rat LDH-X was raised in rabbits. Polyacrylamide gel containing the C4 band was cut out, minced, and homogenized in complete Freund's adjuvant (Cappel Laboratories, Downington, PA). One Adsorption of the Antiserum. Rabbit anti-rat LDH-X antiserum crossreacts with mouse LDH-X and stains both rat and mouse sperm in the fluorescent antibody technique described later. Gamma globulin fraction from the antiserum was isolated by precipitation with 18% sodium sulfate. After extensive dialysis against phosphate-buffered saline (pH 7.2), it was absorbed once with plain Sepharose-4B, four times with mouse LDH-X immunoabsorbent, and once with DBA/2 mouse sperm. The resulting preparation was specific for rat LDH-X and did not show any crossreaction with mouse LDH-X as judged by fluorescent staining of rat sperm and lack of staining of mouse sperm.
Immunodiffusion. Ouchterlony (6) double diffusion was carried out with Agarose immunodiffusion tablets (no. 170-3002, Bio-Rad). The tablet was dissolved in water and poured on a plate to obtain 1% agarose gel in Tris-buffered isotonic saline (pH 7.2). The plate was incubated at room temperature until precipitin bands were well developed.
Precipitin Titration. Quantitative precipitin titration (7) was carried out as described (8) .
Fluorescein Isothiocyanate-Coupled Goat Anti-Rabbit IgG. Fluorescein isothiocyanate isomer I (FITC) was obtained from Sigma. Goat antiserum against rabbit IgG was obtained from Cappel Laboratories (Cochranville, PA). The gamma globulin fraction was isolated from the antiserum by precipitation with 18% sodium sulfate and dialyzed against 50 mM carbonate/bicarbonate buffer, pH 9.4. FITC labeling of the protein was done according to a slight modification of the method described by Nairn (9) . The labeled protein was purified by DEAE-cellulose chromatography and absorbed once with mouse liver powder and twice with DBA/2 sperm.
Procarbazine Treatment of Mice. Procarbazine (N-isopropyl-a-(2-methylhydrazino)-p-toluamide monohydrochloride, NSC-77213), obtained from Hoffmann-LaRoche was dissolved in sterile isotonic saline immediately before use. One milliliter of the solution was injected intraperitoneally into 8-to 10-week old DBA/2 mice (Jackson Laboratory). One set of mice received single injections of varying doses (0, 200, 400, 600, and 800 mg/kg). Another set received three injections at days 1, 2, and 5; in this set, the individual doses were 100 and 200 mg/kg (total dosages, 300 and 600 mg/kg). Animals were sacrificed 7 weeks (second set) or 10-12 weeks (first set) after the treatment. The selection of doses was based upon the results of previous dominant lethal studies (10) and biochemical specific-locus test (11) with procaEbazine. The selection of the time between treatment and sacrifice was based upon the facts that it takes at least 41 days for a stem cell to differentiate into a mature sperm (12) and that mice undergo a temporary phase of sterility after procarbazine treatment (13) .
Sperm Preparation. Sperm from DBA/2 mice and CD-I rats were gently stripped from vas deferens soon after the animals were sacrificed. All sperm were washed twice with cold phosphate-buffered saline (pH 7.2) by centrifugation. 
RESULTS
Rabbit antisera against rat C4 showed no crossreaction with rat or mouse LDH-A and LDH-B. However, a strong crossreaction was observed with mouse LDH-X (Fig. 1) . The spur in Fig. 1 clearly shows that the anti-rat LDH-X antiserum contained some antibody directed against antigenic determinant(s) present in rat LDH-X but not in mouse LDH-X. The precipitin titration curve (Fig. 2) gave a more precise estimate of such an antibody population in the antiserum. With the homologous antigen (rat LDH-X), 6 .2 mg of antibody could be precipitated from 1 ml of the antiserum, whereas mouse LDH-X could precipitate only 5.6 mg (90%) of the antibody. Thus, at least 90% of the antibody was directed against antigenic determi- nants common between mouse and rat LDH-X. A part of the remaining 10% may be directed against determinants "unique" to the rat enzyme. After absorption of the antiserum with mouse LDH-X immunoabsorbent, all the precipitating activity of the antiserum disappeared; the absorbed antiserum gave no precipitin lines with either mouse or rat LDH-X. However, absorbed serum contained nonprecipitating antibodies that reacted with rat LDH-X but not with mouse LDH-X. To make the system cleaner, gamma globulin fraction from the unabsorbed antiserum was isolated by 18% sodium sulfate precipitation and then absorbed extensively on mouse LDH-X immunoabsorbent and on mouse sperm. This absorbed antibody preparation reacted with rat sperm but not with mouse sperm and is designated "rabbit anti-rat LDH-X (mouse-)." Excellent immunofluorescent staining of rat sperm was obtained with this preparation and therefore no attempt was made to isolate the specific antibody from the gamma globulin fraction by affinity chromatography.
Immunofluorescent Staining. The whole unabsorbed rabbit anti-rat LDH-X antiserum, in the sandwich fluorescent antibody technique using FITC-goat anti-rabbit IgG, stained both rat and mouse sperm. When mouse sperm was treated with the unabsorbed rabbit anti-rat LDH-X antiserum and FITC-goat anti-rabbit IgG, the entire sperm, including head, midpiece, and tail, was stained (Fig. 3) . Similar staining pattern is obtained with rat sperm. However, after the serum was absorbed with plain Sepharose-4B, only the tail of mouse and rat sperm was stained (Fig. 4) . This staining pattern is consistent with our previous observation that the rabbit serum contains antisaccharide antibodies that bind to membrane carbohydrate covering the sperm surface and result in the nonspecific staining of the entire sperm (unpublished data). After treatment of the antiserum with plain Sepharose-4B, these antisaccharide antibodies are absorbed out. Because the sperm membrane is not broken open during our staining procedure, staining takes place only on the surface and the antibody does not reach the mitochondria; therefore, only the tail surface is stained with the Sepharose-absorbed antiserum. Further absorption of the antiserum or of the gamma globulin fraction of the antiserum on mouse LDH-X and on mouse sperm resulted in a specific antibody preparation that reacted with rat LDH-X and not with mouse LDH-X. This antibody preparation stains only the tail of rat sperm and not mouse sperm (Fig. 5) .
Specificity of the Rabbit Anti-Rat LDH-X (Mouse -). A further check of the specificity of the antibody was made by inhibition studies. Addition of rat LDH-X to the purified antibody before use of the latter in the sandwich fluorescent antibody technique completely inhibited staining of rat sperm. In a parallel experiment, mouse LDH-X was not able to inhibit the staining. These observations clearly demonstrated the specificity of the purified antibody.
Demonstration That the Fluorescent Staining Is Due to Intrinsic Enzyme of the Sperm and Not Due to Enzyme Just Adsorbed to the Sperm from Semen. The fact that only the tail stained indicates that the staining was not due to enzyme ab- sorbed to the sperm from the semen. To investigate this point further, unwashed rat and mouse sperm were mixed in different proportions from 1:1 to 1:100,000 and allowed to adsorb LDH-X from the medium for 4 hr. They were then stained with rabbit anti-rat LDH-X (mouse -) by the standard procedure. Again, only the rat sperm were stained; no mouse sperm was stained. If the sperm were picking up some enzyme from the medium, some mouse sperm would also have been labeled.
Counting of Cells in Artificial Mixtures. The results of experiments testing reliability of the antibody in detecting sperm bearing mutant LDH-X are summarized in Table 1 . In these experiments, artificial mixtures containing rat and mouse sperm in ratios from 1 X 10-5 to 1 X 10-6 were prepared. These mixtures were stained in suspension with the purified anti-rat LDH-X (mouse -) antibody and FITC-goat anti-rabbit antibody. Fifty microliters of the sperm suspension, containing a known number of sperm, was spread on a slide in 1.6 X 3.2 cm 7.60 X 10-6 Sperm were collected 10-12 weeks after the treatment. Sperm from at least 10 mice were pooled in each group.
area. After the slides were air dried, the fluorescent sperm were counted under a fluorescence microscope. Excellent correlation of the observed proportion of antibody-binding sperm with the known proportion of rat sperm was obtained.
Frequency of Stained Sperm in Treated and Untreated Mice. Table 2 shows the frequency data for untreated and single-dose-treated mice. Of 167 X 106 sperm from untreated mice, 72 stained with the anti-rat LDH-X (mouse -) antibody, corresponding to a frequency of 0.43 X 10-6. The frequency increased proportionally with increasing dose of procarbazine. An 18-fold increase in the frequency was observed at the highest dose (800 mg/kg). Similar results were obtained in a blind screening in which the authors and the technicians did not know the code. Table 3 shows results of the multiple injections of procarbazine. Again, a frequency of 0.4 X 10-6 was obtained for the untreated group. The frequency for 300 mg/kg group is between that for the 200 mg/kg group and that for the 400 mg/kg group in Table 2 . Also, the frequency for 600 mg/kg cumulative dose (Table 3 ) is close to the value for the 600 mg/kg single dose group (Table 2) . These results indicate that procarbazine has a cumulative dose effect. (23) . By applying the same principles, it should be possible to study mutation in sperm with antibodies against LDH-X. The immunological difference between mouse and rat LDH-X permitted the isolation of an antibody fraction that bound rat LDH-X but not mouse LDH-X. This antibody Procarbazine was chosen to test the LDH-X/anti-LDH-X system because it is known to cause mutation in the spermatogonia (10, 11) . The linear dose-response relationship obtained (Tables 2 and 3 ) clearly demonstrated the promise of the system. The positive fluorescent staining of the presumptive mutant mouse sperm cannot be accounted for by posttranslational modification of LDH-X by procarbazine because newly differentiated sperm from stem cells were collected for the study several weeks after the treatment, when procarbazine had been metabolized and eliminated from the body. The antibody used in these studies is highly specific for rat LDH-X and does not bind to mouse LDH-X. The most likely explanation for increase in the frequency of stained sperm with increase in the dose of a known mutagen is that the system is detecting a mutation in the mouse sperm in which amino acid(s) in the mouse LDH-X are replaced by amino acid(s) normally present in rat LDH-X at that particular position in the polypeptide chain. The evidence presented in this paper concerning the mutant nature of the positively stained mouse sperm is only circumstantial. Further circumstantial evidence could be obtained by demonstrating complete lack of the immunofluorescent staining of the sperm from procarbazine-treated mice when the monospecific antibody was used after preincubation with rat LDH-X. However, a positive demonstration that the fluorescently stained mouse sperm do contain mutant LDH-X is essential.
DISCUSSION
Comparison of the amino acid sequences of rat and mouse LDH-X in the loop region 98-115 reveals two differences: at position 108, mouse has threonine and rat has serine; at position 111, mouse has aspartic acid and rat has alanine (24, 25) . Single base-pair substitutions can account for both of these amino acid changes.
After full validation, the cell specific-locus test described in this paper could be used as an in vwo, mammalian, short-term screening test for mutagens and carcinogens.
